Home › Asset managers › Compare 2023-2024 › John Hancock vs Jackson National
John Hancock 2023-2024 · Jackson National 2023-2024 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 63,175 | 55,649 | 619 | 6,907 | 98.9% | 94.9% |
| Board proposals | 50,091 | 43,939 | 528 | 5,624 | 98.8% | 94.8% |
| E&S shareholder proposals | 399 | 106 | 24 | 269 | 81.5% | 57.3% |
| Other items | 12,685 | 11,604 | 67 | 1,014 | 99.4% | 96.8% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
528 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | John Hancock | Jackson National |
|---|---|---|---|---|---|---|
| VENTYX BIOSCIENCES INC. | June 5, 2024 | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2023 Summary Compensation Table in the "Executive Compensation" section of the proxy statement (the "Say-on-Pay Vote"). Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| VERASTEM INC. | May 23, 2024 | To approve an advisory vote on the compensation of the named executive officers Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| VERVE THERAPEUTICS INC. | June 6, 2024 | Approval, on an advisory basis, of the compensation paid to our named executive officers Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| VERVE THERAPEUTICS INC. | June 6, 2024 | Election of two Class III directors to our board of directors, each to serve until the 2027 annual meeting of stockholders: Burt Adelman, M.D. Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 1 fund |
| VISIONAL,INC. | October 25, 2023 | Appoint a Director who is not Audit and Supervisory Committee Member Minami, Soichiro Director Elections |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| VISIONAL,INC. | October 25, 2023 | Appoint a Director who is not Audit and Supervisory Committee Member Murata, Satoshi Director Elections |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| VISIONAL,INC. | October 25, 2023 | Appoint a Director who is not Audit and Supervisory Committee Member Sakai, Tetsuya Director Elections |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| VISIONAL,INC. | October 25, 2023 | Appoint a Director who is not Audit and Supervisory Committee Member Takeuchi, Shin Director Elections |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| VITROX CORPORATION BHD | May 24, 2024 | TO RE-APPOINT MESSRS. CROWE MALAYSIA PLT AS AUDITORS OF THE COMPANY FOR THE ENSUING YEAR AND TO AUTHORISE THE DIRECTORS TO FIX THEIR REMUNERATION Audit-related |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| VOYAGER THERAPEUTICS INC. | June 5, 2024 | To elect each of the following directors to serve as a Class III director until the 2027 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Michael Higgins Director Elections |
Board | For | FOR 2 funds |
ABSTAIN 1 fund |
| WAERTSILAE CORP. | March 7, 2024 | REELECT KAREN BOMBA, MORTEN H. ENGELSTOFT, KARIN FALK, JOHAN FORSSELL, TOM JOHNSTONE (CHAIR), MATS RAHMSTROM, TIINA TUOMELA AND MIKA VEHVILAINEN (VICE-CHAIR) AS DIRECTORS Director Elections |
Board | For | AGAINST 3 funds |
FOR 3 funds |
| WARBY PARKER INC. | June 7, 2024 | Election of Directors: Neil Blumenthal Director Elections |
Board | For | FOR 3 funds |
ABSTAIN 1 fund |
| WESTERN MINING CO LTD. | August 14, 2023 | ELECTION OF INDEPENDENT DIRECTOR: HUANG DAZE Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| WESTROCK COFFEE CO. | June 6, 2024 | Election of Directors R. Patrick Kruczek Director Elections |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| WOODSIDE ENERGY GROUP LTD. | April 24, 2024 | Re-election of Director: Mr Richard Goyder, AO Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| XBIOTECH INC. | June 20, 2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| XERIS BIOPHARMA HOLDINGS INC. | June 5, 2024 | Election of Directors Paul R. Edick Director Elections |
Board | For | FOR 3 funds |
WITHHOLD 1 fund |
| XERIS BIOPHARMA HOLDINGS INC. | June 5, 2024 | Election of Directors Ricki L. Fairley Director Elections |
Board | For | FOR 3 funds |
WITHHOLD 1 fund |
| XIAOMI CORP. | June 6, 2024 | TO APPROVE AND ADOPT THE SHARE INCENTIVE SCHEME, NAMED AS THE 2024 XIAOMI HK SHARE SCHEME (THE 2024 XIAOMI HK SHARE SCHEME) PROPOSED BY THE DIRECTORS, A COPY OF WHICH IS PRODUCED TO THIS MEETING MARKED A AND SIGNED BY THE CHAIRMAN OF THE MEETING FOR THE PURPOSE OF IDENTIFICATION, WITH THE SCHEME MANDATE LIMIT (AS DEFINED IN THE 2024 XIAOMI HK SHARE SCHEME, WHICH INCLUDES AWARDS TO BE GRANTED UNDER ANY OTHER SHARE SCHEMES OF XIAOMI HK) OF 10% OF THE TOTAL ISSUED AND OUTSTANDING XIAOMI HK SHARES (AS DEFINED IN THE CIRCULAR OF THE COMPANY DATED MAY 14, 2024) AS AT THE DATE OF THE SHAREHOLDERS APPROVAL OF THE 2024 XIAOMI HK SHARE SCHEME, BE AND IS HEREBY APPROVED AND ADOPTED, AND THE SCHEME ADMINISTRATOR (AS DEFINED IN THE 2024 XIAOMI HK SHARE SCHEME) BE AND IS HEREBY AUTHORISED TO GRANT THE AWARDS (AWARDS), AND DO ALL SUCH ACTS AND EXECUTE ALL SUCH DOCUMENTS AS THE SCHEME ADMINISTRATOR MAY CONSIDER NECESSARY OR EXPEDIENT IN ORDER TO GIVE FULL EFFECT TO THE 2024 XIAOMI HK SHARE SCHEME Compensation |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| XP INC. | May 24, 2024 | Approval of the appointment of Melissa Werneck as an independent director. Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Y-MABS THERAPEUTICS INC. | June 11, 2024 | Election of Directors: Michael Rossi Director Elections |
Board | For | FOR 3 funds |
ABSTAIN 1 fund |
| Y-MABS THERAPEUTICS INC. | June 11, 2024 | To approve, on a non-binding advisory vote basis, the compensation of the Company's named executive officers as disclosed in the proxy materials. Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| YEXT INC. | June 12, 2024 | Approve, on an advisory basis, the compensation of Yext, Inc.'s named executive officers Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 2 funds |
| YEXT INC. | June 12, 2024 | Election of Class I Directors: Evan Skorpen Director Elections |
Board | For | FOR 4 funds |
ABSTAIN 2 funds |
| YIFENG PHARMACY CHAIN CO LTD. | June 25, 2024 | ELECTION OF NON-INDEPENDENT DIRECTOR: GAO YI Director Elections |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| ZHONGJI INNOLIGHT CO. LTD. | November 8, 2023 | APPRAISAL MANAGEMENT MEASURES FOR THE IMPLEMENTATION OF THE 3RD PHASE RESTRICTED STOCK INCENTIVE PLAN (REVISED DRAFT) Compensation |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| ZHONGJI INNOLIGHT CO. LTD. | November 8, 2023 | AUTHORIZATION TO THE BOARD TO HANDLE MATTERS REGARDING THE 3RD PHASE RESTRICTED STOCK INCENTIVE PLAN Compensation |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| ZHONGJI INNOLIGHT CO. LTD. | November 8, 2023 | THE 3RD PHASE RESTRICTED STOCK INCENTIVE PLAN (REVISED DRAFT) AND ITS SUMMARY Compensation |
Board | For | AGAINST 3 funds |
FOR 1 fund |
← Previous Page 6 of 6
How items are matched and positions counted: see the comparison table and the methodology. Built October 18, 2026 from SEC Form N-PX filings.